Largest pharmaceuticals by total liabilities

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

AbbVie leads the 61 pharmaceuticals ranked by total liabilities, at $137.2B, ahead of Pfizer ($121.4B) and Johnson & Johnson ($117.7B). Figures as of 17 Nov 2026, 17:20 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
61
First
AbbVie$137.2B
Median
$2.1B
Combined market value
$5.17T
Countries
10

Market values as of .

Largest pharmaceuticals by total liabilities
#CompanyTotal liabilities ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AbbVieABBV · Health Care$137.2B$518.2B$293.17 0.47% down 26% up United States
2PfizerPFE · Health Care$121.4B$162.7B$28.54 1.11% down 13% up United States
3Johnson & JohnsonJNJ · Health Care$117.7B$675.4B$280.57 0.70% down 41% up United States
4Eli LillyLLY · Health Care$85.9B$1.26T$1,416.29 1.07% down 39% up United States
5Merck & CoMRK · Health Care$84.2B$354.9B$143.98 0.33% down 50% up United States
6Bristol-Myers SquibbBMY · Health Care$71.5B$124.5B$60.93 3.19% down 34% up United States
7AstraZenecaAZN · Health Care$65.4B$284.4B$183.39 0.34% down 3% up United Kingdom
8NovartisNVS · Health Care$64.4B$301.9B$159.86 0.21% down 25% up Switzerland
9SanofiSNY · Health Care$61.1B$115.1B$47.93 0.96% down 4% down France
10GSKGSK · Health Care$59.9B$99.2B$49.49 1.83% down 6% up United Kingdom
11Novo NordiskNVO · Health Care$51.8B$179.3B$40.69 2.18% down 13% down Denmark
12Takeda PharmaceuticalTAK · Health Care$50.6B$69.4B$21.71 0.56% up 53% up Japan
13Abbott LaboratoriesABT · Health Care$33.9B$184B$106.24 1.13% down 17% down United States
14Teva Pharmaceutical IndustriesTEVA · Health Care$32.8B$49.2B$42.14 1.01% down 71% up Israel
15ViatrisVTRS · Health Care$22.5B$23.7B$20.63 0.53% down 94% up United States
16GrifolsGRFS · Health Care$13.4B$5.9B$8.64 1.03% down 2% up Spain
17ZoetisZTS · Health Care$12.1B$34.1B$83.85 0.64% down 29% down United States
18Royalty PharmaRPRX · Health Care$9.9B$39.3B$68.35 0.26% down 74% up United States
19Regeneron PharmaceuticalsREGN · Health Care$9.3B$99.5B$961.54 0.96% up 31% up United States
20Jazz PharmaceuticalsJAZZ · Health Care$7.3B$15.6B$242.34 1.07% up 33% up Ireland
21GenmabGMAB · Health Care$7B$31.9B$51.80 0.45% up 70% up Denmark
22Vertex PharmaceuticalsVRTX · Health Care$7B$135.5B$534.47 0.62% down 23% up United States
23Elanco Animal HealthELAN · Health Care$6.8B$13B$26.06 1.33% down 23% up United States
24Alnylam PharmaceuticalsALNY · Health Care$4.2B$21.1B$157.19 1.59% down 65% down United States
25BeOne MedicinesONC · Health Care$3.8B$46.9B$410.40 0.22% down 13% up Switzerland
26Amneal PharmaceuticalsAMRX · Health Care$3.7B$7.3B$21.08 0.71% down 83% up United States
27PTC TherapeuticsPTCT · Health Care$3.1B$5B$60.05 1.51% down 20% down United States
28Ionis PharmaceuticalsIONS · Health Care$3B$4.5B$27.05 3.43% down 62% down United States
29BridgeBio PharmaBBIO · Health Care$3B$14.9B$76.63 0.94% down 18% up United States
30Dr. Reddy's LaboratoriesRDY · Health Care$2.1B$12.4B$14.89 1.29% up 5% up India
31CytokineticsCYTK · Health Care$2.1B$7.2B$51.87 2.44% down 20% down United States
32Ascendis PharmaASND · Health Care$1.6B$17.5B$267.14 1.69% down 25% up Denmark
33InsmedINSM · Health Care$1.5B$26.3B$119.75 2.55% down 39% down United States
34BioMarin PharmaceuticalBMRN · Health Care$1.5B$11.3B$58.39 0.69% up 7% up United States
35Arrowhead PharmaceuticalsARWR · Health Care$881.9M$6.1B$43.45 1.73% down 9% up United States
36United TherapeuticsUTHR · Health Care$783.8M$24.7B$579.15 1.48% down 23% up United States
37Legend BiotechLEGN · Health Care$731.6M$3.2B$16.27 1.75% up 46% down United States
38AlkermesALKS · Health Care$667.7M$7.7B$45.54 2.13% down 59% up Ireland
39Madrigal PharmaceuticalsMDGL · Health Care$656.9M$9.9B$426.93 0.70% up 24% down United States
40Axsome TherapeuticsAXSM · Health Care$601.5M$7.2B$136.72 0.21% down 7% down United States
41Ligand PharmaceuticalsLGND · Health Care$543.4M$6B$299.42 0.76% down 46% up United States
42Mirum PharmaceuticalsMIRM · Health Care$528.1M$5.9B$90.88 0.76% down 27% up United States
43Travere TherapeuticsTVTX · Health Care$490.4M$4.8B$50.28 1.17% up 38% up United States
44Roivant SciencesROIV · Health Care$416.3M$27.8B$38.43 0.47% down 88% up United Kingdom
45TG TherapeuticsTGTX · Health Care$415.2M$9.5B$62.88 0.19% up 101% up United States
46Cogent BiosciencesCOGT · Health Care$301.2M$4.7B$26.98 1.68% down 18% down United States
47Rhythm PharmaceuticalsRYTM · Health Care$210.2M$7.9B$113.72 5.80% up 7% up United States
48Kiniksa Pharmaceuticals InternationalKNSA · Health Care$196M$7.4B$94.56 0.35% up 128% up United Kingdom
49Corcept TherapeuticsCORT · Health Care$188.8M$7.8B$71.13 2.75% up 8% down United States
50ABIVAXABVX · Health Care$143.3M$7.3B$83.30 0.37% down 27% down France
51Definium TherapeuticsDFTX · Health Care$107.8M$4B$29.36 2.64% down 164% up United States
52Summit TherapeuticsSMMT · Health Care$92.3M$8.7B$10.94 7.49% down 30% down United States
53ErascaERAS · Health Care$71M$5.1B$14.57 3.57% down 428% up United States
54Spyre TherapeuticsSYRE · Health Care$62.5M$9B$94.95 4.45% down 312% up United States
55Praxis Precision MedicinesPRAX · Health Care$59.8M$8.6B$308.39 0.61% down 69% up United States
56Protagonist TherapeuticsPTGX · Health Care$53.5M$8.2B$125.30 0.38% up 48% up United States
57Dianthus TherapeuticsDNTH · Health Care$37.5M$4.9B$87.28 2.54% down 119% up United States
58Edgewise TherapeuticsEWTX · Health Care$30.3M$4.6B$42.05 3.73% down 97% up United States
59Oruka TherapeuticsORKA · Health Care$16.7M$6.6B$96.66 2.60% down 262% up United States
60Belite BioBLTE · Health Care$10.1M$6.3B$157.15 3.33% down 32% up United States
61VeradermicsMANE · Health Care$9.2M$5.3B$126.39 1.30% down 239% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity.

Questions and answers

Which pharmaceuticals rank first by total liabilities?

AbbVie ($137.2B), Pfizer ($121.4B) and Johnson & Johnson ($117.7B) are the top three of the 61 pharmaceuticals ranked by total liabilities as of 17 Nov 2026, 17:20 UTC.

How many pharmaceuticals are in this ranking?

61 are ranked by total liabilities.

What are these pharmaceuticals worth together?

Their combined market value is $5.17T as of 17 Nov 2026, 17:20 UTC.

What does ranking by total liabilities measure?

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 17 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities

Underlying data: Yahoo Finance; SEC EDGAR.